logo

Insulin Delivery Devices Market Size (2024 - 2029)

The insulin delivery devices market is projected to experience growth over the forecast period, driven by various factors including the impact of the COVID-19 pandemic on diabetes patients, particularly those with Type-1 diabetes. The pandemic highlighted the vulnerability of individuals with diabetes, leading to increased demand for insulin delivery devices as healthcare systems adapted to ensure continued supply. Additionally, technological advancements in these devices have contributed to safer and more accurate insulin administration, further supporting market expansion. The rising prevalence of diabetes, including an increase in Type-2 diabetes patients using insulin delivery devices, also plays a significant role in the market's growth trajectory.

Home Market Analysis Healthcare Research Device Drug Combination Research Diagnostics and Therapeutics Research Diabetes Care Research Insulin Delivery System Industry Market Size

Market Size of Insulin Delivery Devices Industry

Insulin Delivery Devices Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 39.57 Billion
Market Size (2029) USD 47.17 Billion
CAGR (2024 - 2029) 3.57 %
Fastest Growing Market North America
Largest Market Asia Pacific

Major Players

Insulin Delivery Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Insulin Delivery Devices Market Analysis

The Insulin Delivery Devices Market size is estimated at USD 39.57 billion in 2024, and is expected to reach USD 47.17 billion by 2029, growing at a CAGR of 3.57% during the forecast period (2024-2029).

The COVID-19 pandemic substantially impacted the insulin delivery devices market. Type-1 diabetes patients are impacted more during COVID-19. People with diabetes have a weak immune system; hence, with COVID-19, the immune system gets weaker fast. People with diabetes may have more chances of serious complications than normal people. The manufacturers of insulin delivery devices have taken care during COVID-19 to deliver insulin delivery devices to diabetes patients with the help of local governments. NovoNordisk stated on their website that 'Since the start of COVID-19, our commitment to patients, our employees, and the communities where we operate has remained unchanged, we continue to supply our medicines and devices to people living with diabetes and other serious chronic diseases, safeguard the health of our employees, and take actions to support doctors and nurses as they work to defeat COVID-19.' Doctors globally suggest diabetes patients check their diabetes levels more often to be careful. The intake of medicine has increased, leading to an increased usage of insulin delivery devices.

According to International Diabetes Federation (IDF), the adult diabetes population in 2021 was approximately 537 million, and this number is expected to increase by 643 million in 2030. Approximately 10% of the total diabetes population has Type-1 diabetes, and of this 10% of people, only 80-90% use insulin delivery devices; however, the usage of insulin is rising from time to time, and even Type-2 diabetes patients are using the insulin delivery devices during COVID-19.

Technological advancements in insulin delivery devices have increased over time for safer and more accurate insulin administration. Therefore, owing to the factors mentioned above, the studied market is anticipated to witness growth over the analysis period.

Insulin Delivery Devices Industry Segmentation

The insulin delivery devices market is expected to register a CAGR greater than 3% over the forecast period. The insulin delivery devices market is segmented by type (insulin pumps, insulin syringes, cartridges in reusable pens, disposable pens, jet injectors) and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and Latin America). The report offers the value (in USD million) for the above segments. The report also covers the estimated market sizes and trends for 25 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Management Devices
Insulin Pump
Insulin Pump Devices (Value and Volume, 2016 - 2027)
Insulin Pump Reservoirs (Value and Volume, 2016 - 2027)
Infusion Sets (Value and Volume, 2016 - 2027)
Insulin Syringes (Value and Volume, 2016 - 2027)
Cartridges in reusable pens (Value and Volume, 2016 - 2027)
Disposable Pens (Value and Volume, 2016 - 2027)
Jet Injectors (Value and Volume, 2016 - 2027)
Geography
North America
United States (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Canada (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of North America (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Europe
France (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Germany (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Italy (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Spain (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
United Kingdom (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Russia (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Europe (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Latin America
Mexico (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Brazil (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Latin America (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Asia-Pacific
Japan (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
South Korea (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
China (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
India (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Australia (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Vietnam (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Malaysia (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Indonesia (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Philippines (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Thailand (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Asia-Pacific (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Middle-East and Africa
Saudi Arabia (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Iran (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Egypt (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Oman (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
South Africa (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Middle-East and Africa (Value and Volume, 2016 - 2027)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Need A Different Region Or Segment?
Customize Now

Insulin Delivery Devices Market Size Summary

The insulin delivery devices market is poised for significant growth over the forecast period, driven by increasing technological advancements and a rising prevalence of diabetes globally. The market is characterized by the development of innovative devices such as insulin pumps, which offer continuous and more accurate insulin administration compared to traditional methods. These advancements are particularly beneficial for Type 1 diabetes patients, as insulin pumps mimic the human pancreas, providing near-physiological insulin delivery. The market's expansion is further supported by a growing number of vendors, robust research and development activities, and favorable reimbursement scenarios in developed countries. North America is expected to lead the market due to high consumer awareness and the easy availability of these devices, with the United States being a significant contributor due to its large diabetic population and healthcare expenditure.

The COVID-19 pandemic has had a notable impact on the insulin delivery devices market, as individuals with diabetes faced heightened health risks, prompting increased usage of these devices. The market is consolidated, with a few major companies like Novo Nordisk, Sanofi, Eli Lilly and Company, and Medtronic dominating the landscape. These companies continue to innovate and expand their product offerings, such as Novo Nordisk's smart connected insulin pens and Insulet's automated insulin delivery system. The market's growth is also fueled by the rising awareness programs in developing economies and the increasing adoption of insulin delivery devices among Type 2 diabetes patients. As the demand for diabetes care products continues to rise, the insulin delivery devices market is expected to experience sustained growth, with technological advancements playing a crucial role in shaping its future.

Explore More

Insulin Delivery Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. Market Segmentation

    1. 2.1 By Management Devices

      1. 2.1.1 Insulin Pump

        1. 2.1.1.1 Insulin Pump Devices (Value and Volume, 2016 - 2027)

        2. 2.1.1.2 Insulin Pump Reservoirs (Value and Volume, 2016 - 2027)

        3. 2.1.1.3 Infusion Sets (Value and Volume, 2016 - 2027)

      2. 2.1.2 Insulin Syringes (Value and Volume, 2016 - 2027)

      3. 2.1.3 Cartridges in reusable pens (Value and Volume, 2016 - 2027)

      4. 2.1.4 Disposable Pens (Value and Volume, 2016 - 2027)

      5. 2.1.5 Jet Injectors (Value and Volume, 2016 - 2027)

    2. 2.2 Geography

      1. 2.2.1 North America

        1. 2.2.1.1 United States (Value and Volume, 2016 - 2027)

          1. 2.2.1.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 2.2.1.2 Canada (Value and Volume, 2016 - 2027)

          1. 2.2.1.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 2.2.1.3 Rest of North America (Value and Volume, 2016 - 2027)

          1. 2.2.1.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      2. 2.2.2 Europe

        1. 2.2.2.1 France (Value and Volume, 2016 - 2027)

          1. 2.2.2.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 2.2.2.2 Germany (Value and Volume, 2016 - 2027)

          1. 2.2.2.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 2.2.2.3 Italy (Value and Volume, 2016 - 2027)

          1. 2.2.2.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 2.2.2.4 Spain (Value and Volume, 2016 - 2027)

          1. 2.2.2.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 2.2.2.5 United Kingdom (Value and Volume, 2016 - 2027)

          1. 2.2.2.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 2.2.2.6 Russia (Value and Volume, 2016 - 2027)

          1. 2.2.2.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        7. 2.2.2.7 Rest of Europe (Value and Volume, 2016 - 2027)

          1. 2.2.2.7.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      3. 2.2.3 Latin America

        1. 2.2.3.1 Mexico (Value and Volume, 2016 - 2027)

          1. 2.2.3.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 2.2.3.2 Brazil (Value and Volume, 2016 - 2027)

          1. 2.2.3.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 2.2.3.3 Rest of Latin America (Value and Volume, 2016 - 2027)

          1. 2.2.3.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      4. 2.2.4 Asia-Pacific

        1. 2.2.4.1 Japan (Value and Volume, 2016 - 2027)

          1. 2.2.4.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 2.2.4.2 South Korea (Value and Volume, 2016 - 2027)

          1. 2.2.4.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 2.2.4.3 China (Value and Volume, 2016 - 2027)

          1. 2.2.4.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 2.2.4.4 India (Value and Volume, 2016 - 2027)

          1. 2.2.4.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 2.2.4.5 Australia (Value and Volume, 2016 - 2027)

          1. 2.2.4.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 2.2.4.6 Vietnam (Value and Volume, 2016 - 2027)

          1. 2.2.4.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        7. 2.2.4.7 Malaysia (Value and Volume, 2016 - 2027)

          1. 2.2.4.7.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        8. 2.2.4.8 Indonesia (Value and Volume, 2016 - 2027)

          1. 2.2.4.8.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        9. 2.2.4.9 Philippines (Value and Volume, 2016 - 2027)

          1. 2.2.4.9.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        10. 2.2.4.10 Thailand (Value and Volume, 2016 - 2027)

          1. 2.2.4.10.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        11. 2.2.4.11 Rest of Asia-Pacific (Value and Volume, 2016 - 2027)

          1. 2.2.4.11.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      5. 2.2.5 Middle-East and Africa

        1. 2.2.5.1 Saudi Arabia (Value and Volume, 2016 - 2027)

          1. 2.2.5.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 2.2.5.2 Iran (Value and Volume, 2016 - 2027)

          1. 2.2.5.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 2.2.5.3 Egypt (Value and Volume, 2016 - 2027)

          1. 2.2.5.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 2.2.5.4 Oman (Value and Volume, 2016 - 2027)

          1. 2.2.5.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 2.2.5.5 South Africa (Value and Volume, 2016 - 2027)

          1. 2.2.5.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 2.2.5.6 Rest of Middle-East and Africa (Value and Volume, 2016 - 2027)

          1. 2.2.5.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

Insulin Delivery Devices Market Size FAQs

The Insulin Delivery Devices Market size is expected to reach USD 39.57 billion in 2024 and grow at a CAGR of 3.57% to reach USD 47.17 billion by 2029.

In 2024, the Insulin Delivery Devices Market size is expected to reach USD 39.57 billion.

Insulin Pumps Market Report Snapshots

Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)